Chair, Company Screening Committee
Jack has over 30 years of broadly based sales, marketing and general management experience in the medical device industry. His experience includes twenty years with subsidiaries of Johnson and Johnson, and significant experience with early stage companies, in both Domestic and International markets.
As President and CEO, Jack led ICON Interventional Systems through several important stages of fund raising and product development. He successfully raised over $15 million in private funding, licensed a state-of-the-art drug and recruited internationally known clinical investigators to achieve CE mark certification for an innovative coronary stent. He also negotiated the sale of the technology after achieving CE mark, providing substantial non-dilutive funding for new projects.
Prior to joining ICON, Jack served as President of the US subsidiary and Co-Chairman of the Worldwide Operating Committee of Regent Medical, a highly differentiated surgical disposables business. Jack also served on the Board of the Association of Operating Room Nurses Foundation during this time.
Earlier Jack led the Sales and Marketing efforts of CardioGenesis Corporation, a startup in the Interventional Cardiology space. As Vice President, Sales and Marketing he was responsible for driving capital equipment sales into clinical trials, resulting in FDA approval of a new technology for cardiac revascularization. In addition, he directed the launch of a new device into the European market and managed the relationship with distribution partner, Boston Scientific Corporation.
Jack joined Johnson and Johnson Interventional Systems in 1989, where he led startup activities in Europe. He recruited and hired the first vascular stent sales team in the US, and set up the sales management structure, including compensation and administrative functions. As Vice President, Sales and Marketing and member of the Worldwide Franchise Council, he led the sales and marketing team responsible for the most successful launch of a new device in medical products history, the Palmaz-Schatz Coronary Stent, resulting in $300 million domestic and $200 million international sales.
Jack holds a BBA degree from Georgia State University in Atlanta, and has completed Executive Programs at IMD in Lausanne, Switzerland and at INSEAD in Fountainebleu, France.